CN Patent

CN112703000B — 慢性咳嗽、呼吸急促和呼吸困难的治疗

Assigned to Trevi Therapeutics Inc · Expires 2024-05-31 · 2y expired

What this patent protects

本发明涉及用纳布啡组合物治疗患有慢性咳嗽的患者的方法以及用纳布啡组合物治疗与IPF相关的咳嗽、呼吸急促或呼吸困难的方法，其中所述方法在患者中提供治疗作用。

USPTO Abstract

本发明涉及用纳布啡组合物治疗患有慢性咳嗽的患者的方法以及用纳布啡组合物治疗与IPF相关的咳嗽、呼吸急促或呼吸困难的方法，其中所述方法在患者中提供治疗作用。

Drugs covered by this patent

cocaine-hydrochloride (COCAINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN112703000B
Jurisdiction: CN
Classification: —
Expires: 2024-05-31
Drug substance claim: No
Drug product claim: No
Assignee: Trevi Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.